{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:53:47Z","timestamp":1775260427605,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/md.0000000000001665","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T05:34:56Z","timestamp":1449812096000},"page":"e1665","source":"Crossref","is-referenced-by-count":9,"title":["Liver Transplantation in Antituberculosis Drugs-Induced Fulminant Hepatic Failure"],"prefix":"10.1097","volume":"94","author":[{"given":"Xiaoyan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Bo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210309","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/00333549141291S110","article-title":"Data harmonization process for creating the National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas","volume":"129","author":"Elmore","year":"2014","journal-title":"Public Health Rep"},{"key":"R2-1-20210309","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1086\/430786","article-title":"The World Health Organization\/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases","volume":"41","author":"Aziz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R3-1-20210309","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(95)90468-9","article-title":"Anti-tuberculous therapy and acute liver failure","volume":"345","author":"Mitchell","year":"1995","journal-title":"Lancet"},{"key":"R4-1-20210309","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MPG.0b013e3181709464","article-title":"Drug-related hepatotoxicity and acute liver failure","volume":"47","author":"Murray","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R5-1-20210309","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1378\/chest.99.2.465","article-title":"Toxic hepatitis with isoniazid and rifampin. A meta-analysis","volume":"99","author":"Steele","year":"1991","journal-title":"Chest"},{"key":"R6-1-20210309","first-page":"735","article-title":"Update: adverse event data and revised American Thoracic SocietyCDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infectionUnited States, 2003.","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-1-20210309","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R8-1-20210309","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/BF02090381","article-title":"Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation","volume":"39","author":"Farrell","year":"1994","journal-title":"Dig Dis Sci"},{"key":"R9-1-20210309","first-page":"905","article-title":"Successful treatment of multidrug-resistant tuberculosis following drug-induced hepatic necrosis requiring liver transplant","volume":"8","author":"Marra","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"R10-1-20210309","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1111\/j.1600-6143.2005.01065.x","article-title":"Is liver transplantation advisable for isoniazid fulminant hepatitis in active extrapulmonary tuberculosis?","volume":"5","author":"Barcena","year":"2005","journal-title":"Am J Transplant"},{"key":"R11-1-20210309","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/lt.20839","article-title":"Antituberculous therapy-induced fulminant hepatic failure: successful treatment with liver transplantation and nonstandard antituberculous therapy","volume":"12","author":"Idilman","year":"2006","journal-title":"Liver Transpl"},{"key":"R12-1-20210309","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1399-3062.2007.00277.x","article-title":"Orthotopic liver transplantation for subacute hepatic failure following partial treatment of isoniazid-resistant tuberculosis","volume":"10","author":"Nash","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"R13-1-20210309","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1016\/j.transproceed.2009.01.118","article-title":"Successful liver transplantation in antituberculosis therapy-induced acute fulminant hepatic failure","volume":"41","author":"Schneider","year":"2009","journal-title":"Transplant Proc"},{"key":"R14-1-20210309","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1432-2277.2009.00921.x","article-title":"Low N-acetyltransferase 2 activity in isoniazid-associated acute hepatitis requiring liver transplantation","volume":"23","author":"Cramer","year":"2010","journal-title":"Transpl Int"},{"key":"R15-1-20210309","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s10620-014-3072-z","article-title":"Isoniazid hepatotoxicity requiring liver transplantation","volume":"59","author":"Sheen","year":"2014","journal-title":"Dig Dis Sci"},{"key":"R16-1-20210309","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.3748\/wjg.15.2817","article-title":"Drug-induced liver injury: is it somehow foreseeable?","volume":"15","author":"Tarantino","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R17-1-20210309","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.stem.2008.08.001","article-title":"Notch signaling regulates mammary stem cell function and luminal cell-fate commitment","volume":"3","author":"Bouras","year":"2008","journal-title":"Cell Stem Cell"},{"key":"R18-1-20210309","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:51:02Z","timestamp":1620960662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201512080-00001"}},"subtitle":["A Case Report and Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":18,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001665","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}